Abstract: The present invention relates to a measuring device for measuring the arching of an elongate body. The measuring device includes an anvil member against which the elongate body is intended to be placed, a measure-collection member movable along the line of the longitudinal axis of the elongate body via a driving unit included in the measuring device, which measure-collection member is connected to a processor unit for the processing of measured values. Furthermore, the measuring device includes a force-transmission member for applying a predetermined force (F), where F>0 N, to the elongate body. The measure-collection member measures continuously, in abutment against and movement along the line of the longitudinal axis of the elongate body, a length (y) and a height (x) between the elongate body and the measuring device, and delivers a digital signal to the processor unit, which calculates the arching (A).

Abstract: The present invention relates to a measuring device (10) for measuring the arching (A) of an elongate body (12). The measuring device (10) comprises an anvil member (14) against which the elongate body (12) is intended to be placed, a measure-collection member (16) movable along the line of the longitudinal axis of the elongate body (12) via a driving unit included in the measuring device (10), which measure-collection member is connected to a processor unit (18) for the processing of measured values. Furthermore, the measuring device (10) comprises a force-transmission member (20) for applying a predetermined force (F), where F?0 N, to the elongate body (12). The measure-collection member (16) measures continuously, in abutment against and movement along the line of the longitudinal axis of the elongate body (12), a length (y) and a height (x) between the elongate body (12) and the measuring device (10), and delivers a digital signal to the processor unit (18), which calculates the arching (A).

Abstract: The use of a physiologically innocuous ammonium compound and/or urea as an additive to an infant formula or a pap or for the preparation of a pharmaceutical composition for the prophylaxis of sudden infant death syndrome (SIDS) is disclosed as is also, an infant formula or a pap which in addition to conventional ingredients contains a physiologically innocuous ammonium compound an/or urea. Furthermore, a method of preventing SIDS is disclosed, which method comprises administering to the infant an infant formula or a pap as indicated above, and a method for prophylaxis of SIDS, wherein a pharmaceutical composition containing a physiologically innocuous ammonium compound and/or urea is administered to the infant or the appropriately selected or modified non-pathogenic, urease-producing bacteria are supplied to the gastrointestinal tract of the infant.

Abstract: A method of preserving bodily protein stores such as skeletal muscle mass in a catabolic patient involves the concomitant administration (a) &agr;-KG and/or &agr;-KGA and (b) ammonium in amounts effective to preserving skeletal muscle. Also disclosed is the combination of a first pharmaceutical composition comprising &agr;-KG and/or &agr;-KGA in a pharmaceutically acceptable carrier and a second pharmaceutical composition comprising ammonium in a pharmaceutically acceptable carrier, in amounts effective to preserving skeletal muscle.

Abstract: The use of a physiologically innocuous ammonium compound and/or urea as an additive to an infant formula or a pap or for the preparation of a pharmaceutical composition for the prophylaxis of sudden infant death syndrome (SIDS) is disclosed as is also an infant formula or a pap which in addition to conventional ingredients contains a physiologically innocuous ammonium compound and/or urea. Futhermore, a method of preventing SIDS is disclosed, which method comprises administering to the infant an infant formula or a pap as indicated above, and a method for the prophylaxis of SIDS, wherein a pharmaceutical composition containing a physiologically innocuous ammonium compound and/or urea is administered to the infant or the appropriately selected or modified non-pathogenic, urease-producing bacteria are supplied to the gastrointestinal tract of the infant.

Abstract: Apparatus for treatment of circulatory arrest includes a manually operated ultrasound probe (1) for localizing and puncture of a superficial artery (2) with a cannula (8) by which, subsequently, a catheter (10) is inserted towards the heart. The catheter (10) contains an elastically inflatable balloon (14,15) by which the distal aorta can be occluded, thereby making possible the injection of concentrated fluid through openings in the distal part of the catheter (10) from an ampoule (19) containing agents for activation of the cardiac muscle, for blood vessel dilation, for dissolving of blood clots or for protection against hypoxic injuries. The apparatus is controlled by a program stored in a memory unit (41) of a central processing unit (40). One or more pressure sensors (23), driving units (22), and pressure generators (21) are used to control the sequential processes.